 The FDA may request sufficient technical information from the processor to evaluate adequacy of the equipment and the procedures used to produce a commercially sterile product.Until the FDA finds no further objections to a process filing, the company is prevented from distributing product produced on that system in interstate commerce.Final aseptic products must undergo an incubation test before the product is released into distribution.